aliquot

Incretin-related

Exenatide

A web reference identity with an FDA label and route-specific human pharmacokinetic information for the named product.

Canonical ID
exenatide
Evidence type
FDA regulatory record
Human PK
2.4 hours

Overview

Aliquot keeps the reviewed formulation context explicit and does not transfer its pharmacokinetic statement to other exenatide formulations.

The public record is limited to regulatory status and pharmacokinetic context from the reviewed label. Aliquot does not combine differing formulations or summarize outcomes.

Human pharmacokinetic context

2.4 hours

FDA prescribing information · subcutaneous injection

Half-life is descriptive population context, not a dosing interval, a prediction of an individual's response, or a recommendation. Route-mismatched and uncited estimates are withheld.

Limitations

  • The reviewed pharmacokinetic statement applies to the named immediate-release exenatide product.
  • Different formulations cannot be assumed to share the same release or pharmacokinetic profile.
  • A population half-life is not an individual prediction or a dosing interval.

Related calculation tools

Aliquot's browser-only tools transform values you already have. They do not select a compound, suggest an amount, provide presets, or store your entries.

View all tools Convert mg and mcg

Sources

  1. Byetta (exenatide) prescribing information FDA prescribing information · U.S. Food and Drug Administration · accessed 2026-07-28 Regulatory status and approximately 2.4-hour terminal half-life after subcutaneous administration.
  2. Aliquot compound library methodology Editorial methodology · Aliquot · accessed 2026-07-28 Editorial scope and formulation-specific withholding rules.

Aliquot Compound Library

Before you browse

Aliquot's Compound Library is an educational reference. Here is how to read and use it.

Educational, not medical advice

The library does not diagnose, treat, prevent, recommend a compound, or replace a licensed clinician. Consult a qualified clinician for personal health decisions.

Evidence has boundaries

Summaries draw from cited public regulator records, peer-reviewed human studies, PubMed records, and trial registrations. A citation does not make a claim conclusive.

No community health profiles

Aliquot does not collect community protocols or outcomes for this library. Calculator entries remain in your browser tab and are not submitted or saved.

Content and reuse

Aliquot's original editorial text and presentation may not be copied, scraped, mirrored, or redistributed without written permission. Linked sources remain subject to their publishers' terms.

This acknowledgement is stored only in this browser. No health or calculator data is included.

Methodology Terms

Reviewed by Aliquot editorial review on 2026-07-28. Next scheduled review: 2026-10-26. Methodology and corrections.